Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-28 · accession 0000950170-24-065983 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-29 | 2024-05-28 | KYTX | Jones Ryan Alexander | CFO | M - OptEx | $0.73 | +18.0K | 44.0K | +69% | +$13.2K |
| DM | 2024-05-29 | 2024-05-28 | KYTX | Jones Ryan Alexander | CFO | M - OptEx | $0.00 | -18.0K | 2,192 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 10,870 | $0.73 | 36,804 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-28 | M | A | 7,146 | $0.73 | 43,950 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-28 | M | D | 10,870 | $0.00 | 0 | D | $0.73 · — to — | 10,870 Common Stock | (F1) 25% of the original number of shares subject to the option vested on April 15, 2021, and 1/48th of the original number of shares subject to the option vested in monthly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-05-28 | M | D | 7,146 | $0.00 | 2,192 | D | $0.73 · — to — | 7,146 Common Stock | (F2) 25% of the original number of shares subject to the option vested on January 1, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |